Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner
  • Home
  • Episodes
  • About
  • Be a guest
  • Memoirs
  • Get in touch
Search Close
Back to blog

Molecule to Market Memoir: Dr Adriana Kiędzierska-Mencfeld

November 13

Memoirs

From Poland to Building a Biologics Future

I really liked Adriana. Although I did find her surname quite the challenge to pronounce LOL!

She is smart, classy, humble and energetic, but what came through most strongly was how much pride she has in Poland and what she has helped build there.

That really resonated with me. I have always taken a lot of pride in building businesses headquartered in my home city of Newcastle, so I completely understand the appeal of creating something meaningful in the place you are from. Making an impact on the streets you were raised and educated.

Adriana could easily have followed a more obvious path elsewhere like many previous guests have done like move to Germany, the UK or US. Instead, she chose to stay and help build a biologics ecosystem in Poland at a time when there really was not much of one. That takes commitment.

What I also admired was the breadth of her experience. She has done a bit of everything. Science. Process development. Manufacturing. Ops. Commercial. Regulatory approvals. And now CEO of Rezon Bio.

You can tell that matters. She is not leading from a distance. She understands the business inside out because she has actually done so many of the jobs herself. And that comes through her view on leadership. She talked about the CEO role being less about managing the organisation and more about creating the conditions for people to achieve things they did not think were possible. That felt very genuine. I loved that I have to say.

And it fits with the way she came across in person as well. Someone who will set high standards, push people, support them and then give them the space to fly. There was also a strong sense of purpose throughout the conversation.

For Adriana, it seems this has never just been about titles or career progression. It is about doing work that matters, building something meaningful and ultimately helping get important medicines to patients. Now she has the challenge of taking all of that heritage and experience and turning it into a genuinely client centric, global biologics CDMO business.

Not easy. But if you want someone leading that kind of transformation, having a CEO who understands the science, the operations, the commercial side and the people piece feels like a pretty good place to start.

🎧 Hear the full episode here: Apple | Spotify

As always, thank you to our sponsors Bora Pharmaceuticals and Lead Candidate for supporting Molecule to Market 🙌

© 2026 Molecule to Market Made By Creatives

Molecule to Market is owned by Raman Sehgal Consulting Corp, 108 College Street, Suite W754, Toronto, M5G0C6, Ontario, Canada